Single nerve conduction study in GBS: is it sufficient?

The diagnosis of GBS is a clinically based.  Nerve conduction studies are utilized to confirm the type of GBS, i.e. demyelinating versus axonal.  Serial nerve conduction studies have been proposed as a means of confirming whether an”apparently” axonal form of GBS represent distal demyelination.  Such confirmation has prognostic implications for the patients.  In addition, previous […]

Read More…

Intracerebral haemmorhage (ICH): Grave prognosis indeed

Strokes are invariably a clinical biomarker of “unwellness” of the central nervous system leading potentially life long disability and shorter survivial.  While there is good prognostic data peratining to ischeamic strokes, that of ICH remains unknown.  As a neurology trainee it was implied, largely from consensus, that ICH strokes exhibit a better prognosis. In this […]

Read More…

Autologous haematopoietic stem cell transplantation in CIDP: Taking a hammer to the walnut?

Chronic inflammatory demyelinating neuropathy (CIDP) remains a difficult disorder to treat, particularly when patients fail to respond to one of the first line therapies.  In addition, complications relating steroid and impressive treatments remain high    and disability for this disorder is invariably a difficult management problem.  In the June issue of JNNP, the utility of […]

Read More…

Natiluzimab therapy: Safe after all?

The efficacy of natiluzimab therapy was established in clinical trials.  It soon, emerged, however that this “life changing” medication was potentially associated with a devastating infectious disorder of the brain, progressive multifocal leucoencephalopathy (PML).  This side-effect resulted in withdrawal of the medication from clinical use for a period of time.  Since re-introduction rigorous screening and […]

Read More…

Perivascular hyperintensities and cognitive impairment: No link

The detection of T2 hyperintensities within the CNS, often termed small vessel disease, has been linked to development of cognitive impairment and is though to be driven by vascular risk factors such as hypertension.  MRI-visible perivascular spaces (PVS), see fig below, appear to be reliable MRI bio-markers of small vessel disease and have been associated […]

Read More…